• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Efficacy of anti-severe acute respiratory syndrome coronavirus 2 mRNA vaccines in adults with severe acquired aplastic anemia with or without allogeneic hematopoietic stem cell transplantation.

作者信息

Garnier Alice, Bourgeois Amandine Le, Guillaume Thierry, Peterlin Pierre, Jullien Maxime, Coste-Burel Marianne, Béné Marie C, Chevallier Patrice

机构信息

Department of Clinical Hematology CHU de Nantes Nantes France.

CNRS, INSERM, CRCI2NA Université de Nantes Nantes France.

出版信息

EJHaem. 2022 Sep 28;3(4):1442-1444. doi: 10.1002/jha2.570. eCollection 2022 Nov.

DOI:10.1002/jha2.570
PMID:36733664
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9885527/
Abstract
摘要

相似文献

1
Efficacy of anti-severe acute respiratory syndrome coronavirus 2 mRNA vaccines in adults with severe acquired aplastic anemia with or without allogeneic hematopoietic stem cell transplantation.抗严重急性呼吸综合征冠状病毒2信使核糖核酸疫苗在接受或未接受异基因造血干细胞移植的严重获得性再生障碍性贫血成人患者中的疗效。
EJHaem. 2022 Sep 28;3(4):1442-1444. doi: 10.1002/jha2.570. eCollection 2022 Nov.
2
Immunogenicity and Safety of Booster SARS-CoV-2 mRNA Vaccine Dose in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.异基因造血干细胞移植受者加强型 SARS-CoV-2 mRNA 疫苗接种的免疫原性和安全性。
Transplant Cell Ther. 2023 Nov;29(11):706.e1-706.e7. doi: 10.1016/j.jtct.2023.08.008. Epub 2023 Aug 13.
3
Safety and Tolerability of SARS-CoV2 Emergency-Use Authorized Vaccines for Allogeneic Hematopoietic Stem Cell Transplant Recipients.异基因造血干细胞移植受者使用紧急授权的 SARS-CoV2 疫苗的安全性和耐受性。
Transplant Cell Ther. 2021 Nov;27(11):938.e1-938.e6. doi: 10.1016/j.jtct.2021.07.008. Epub 2021 Jul 15.
4
Severe aplastic anemia after COVID-19 mRNA vaccination: Causality or coincidence?新冠病毒 mRNA 疫苗接种后发生严重再生障碍性贫血：是因果关系还是巧合？
J Autoimmun. 2022 Jan;126:102782. doi: 10.1016/j.jaut.2021.102782. Epub 2021 Dec 14.
5
First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia.与一线使用环孢素和/或抗胸腺细胞或抗淋巴细胞球蛋白治疗获得性重型再生障碍性贫血相比，HLA匹配的同胞供者进行一线异基因造血干细胞移植的情况。
Cochrane Database Syst Rev. 2013 Jul 23;2013(7):CD006407. doi: 10.1002/14651858.CD006407.pub2.
6
A Third Dose COVID-19 Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation Patients.异基因造血干细胞移植患者的第三剂新冠疫苗接种
Vaccines (Basel). 2022 Oct 29;10(11):1830. doi: 10.3390/vaccines10111830.
7
Is a third SARS-CoV-2 vaccine dose efficient in allogeneic haematopoietic cell transplant recipients?异体造血干细胞移植受者接种第三剂 SARS-CoV-2 疫苗有效吗？
Br J Haematol. 2023 Apr;201(1):9-10. doi: 10.1111/bjh.18591. Epub 2022 Dec 7.
8
Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients.异基因造血干细胞移植受者对 BNT162b2 疫苗的中和抗体反应的预测因素。
J Hematol Oncol. 2021 Oct 24;14(1):174. doi: 10.1186/s13045-021-01190-3.
9
Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Immunogenicity and Reactogenicity.异体造血干细胞移植受者的严重急性呼吸综合征冠状病毒 2 信使 RNA 疫苗：免疫原性和反应原性。
Clin Infect Dis. 2022 Aug 24;75(1):e920-e923. doi: 10.1093/cid/ciab930.
10
Third BNT162b2 mRNA SARS-CoV-2 Vaccine Dose Significantly Enhances Immunogenicity in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.第三剂BNT162b2 mRNA新冠病毒疫苗显著增强异基因造血干细胞移植受者的免疫原性。
Vaccines (Basel). 2023 Mar 31;11(4):775. doi: 10.3390/vaccines11040775.

本文引用的文献

1
COVID-19 vaccination antibody responses in patients with aplastic anaemia and paroxysmal nocturnal haemoglobinuria.再生障碍性贫血和阵发性睡眠性血红蛋白尿患者的新冠病毒疫苗接种抗体反应
Lancet Haematol. 2022 Aug;9(8):e553-e556. doi: 10.1016/S2352-3026(22)00183-1. Epub 2022 Jul 1.
2
Acquired aplastic anemia following SARS-CoV-2 vaccination.接种 SARS-CoV-2 疫苗后获得再生障碍性贫血。
Eur J Haematol. 2022 Aug;109(2):186-194. doi: 10.1111/ejh.13788. Epub 2022 Jun 1.
3
Effectiveness of a third dose of BNT162b2 anti-SARS-CoV-2 mRNA vaccine over a 6-month follow-up period in allogenic hematopoietic stem cells recipients.在异体造血干细胞受者中，BNT162b2 抗 SARS-CoV-2 mRNA 疫苗第三剂在 6 个月随访期内的有效性。
Hematol Oncol. 2022 Dec;40(5):1097-1099. doi: 10.1002/hon.3006. Epub 2022 Apr 29.
4
SARS-CoV-2 infection associated with aplastic anemia and pure red cell aplasia.与再生障碍性贫血和纯红细胞再生障碍相关的新型冠状病毒2型感染
Blood Adv. 2022 Jul 12;6(13):3840-3843. doi: 10.1182/bloodadvances.2022007174.
5
Severe Aplastic Anemia After Receiving SARS-CoV-2 Moderna mRNA Vaccination.接种新冠病毒Moderna mRNA疫苗后发生严重再生障碍性贫血
J Hematol. 2022 Feb;11(1):34-39. doi: 10.14740/jh954. Epub 2022 Feb 26.
6
SARS-CoV-2 vaccination in patients with paroxysmal nocturnal hemoglobinuria: An Italian multicenter survey.阵发性夜间血红蛋白尿患者的新型冠状病毒2型疫苗接种：一项意大利多中心调查。
Am J Hematol. 2022 Jul;97(7):E229-E232. doi: 10.1002/ajh.26545. Epub 2022 Mar 26.
7
Antibody titers after SARS-CoV-2 mRNA vaccination in patients with aplastic anemia-A single-center study.再生障碍性贫血患者接种SARS-CoV-2 mRNA疫苗后的抗体滴度——一项单中心研究
Eur J Haematol. 2022 Jun;108(6):528-531. doi: 10.1111/ejh.13756. Epub 2022 Feb 28.
8
Severe aplastic anemia after COVID-19 mRNA vaccination: Causality or coincidence?新冠病毒 mRNA 疫苗接种后发生严重再生障碍性贫血：是因果关系还是巧合？
J Autoimmun. 2022 Jan;126:102782. doi: 10.1016/j.jaut.2021.102782. Epub 2021 Dec 14.
9
Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients.异基因造血细胞移植受者接种2剂和3剂SARS-CoV-2 mRNA疫苗后的抗体反应。
Blood. 2022 Jan 6;139(1):134-137. doi: 10.1182/blood.2021014232.
10
A case of severe aplastic anaemia after SARS-CoV-2 vaccination.1例新型冠状病毒2型疫苗接种后严重再生障碍性贫血病例。
Br J Haematol. 2022 Mar;196(6):1334-1336. doi: 10.1111/bjh.17947. Epub 2021 Nov 16.